You are here: All Products  > Celregen Therapeutics In-Licenses iPS Therapy for Cornea Transplants in $100 Million Deal

Celregen Therapeutics In-Licenses iPS Therapy for Cornea Transplants in $100 Million Deal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products